Patents Assigned to Acrux DDS PTY LTD
  • Patent number: 10449343
    Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: October 22, 2019
    Assignee: ACRUX DDS PTY LTD
    Inventors: Shu Kuen Chang, Alain Regard, Anastasios G Karahalios, Mark LaFever
  • Publication number: 20170157377
    Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 8, 2017
    Applicant: Acrux DDS Pty Ltd.
    Inventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
  • Publication number: 20170157378
    Abstract: This invention relates to a device, a system and a method for applying a volume of liquid to a treatment surface. The device includes a container for containing the liquid, a pump for extracting liquid from the container, an actuator for operating the pump, and a collapsible receptacle for accommodating extracted liquid.
    Type: Application
    Filed: November 25, 2014
    Publication date: June 8, 2017
    Applicant: ACRUX DDS PTY LTD
    Inventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
  • Publication number: 20160303359
    Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.
    Type: Application
    Filed: February 18, 2016
    Publication date: October 20, 2016
    Applicant: Acrux DDS Pty Ltd
    Inventors: Peter BAYLY, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
  • Publication number: 20160250227
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 6, 2015
    Publication date: September 1, 2016
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • Patent number: 9289586
    Abstract: An implement for applying a volume of liquid to a treatment surface includes a support onto which is mounted a receptacle. The receptacle defines a reservoir space which receives the liquid. The receptacle includes a wall having a working surface that is used to spread the liquid over the treatment surface. The wall is resiliently deformable such that in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement is used in applying a transdermal lotion to the axilla area of a user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same are also provided.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: March 22, 2016
    Assignee: ACRUX DDS PTY LTD
    Inventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
  • Publication number: 20160022820
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: June 10, 2015
    Publication date: January 28, 2016
    Applicant: Acrux DDS Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Patent number: 9180194
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: November 10, 2015
    Assignee: ACRUX DDS PTY LTD
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Patent number: 9078810
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: July 14, 2015
    Assignee: ACRUX DDS PTY LTD
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Publication number: 20150094290
    Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.
    Type: Application
    Filed: June 16, 2014
    Publication date: April 2, 2015
    Applicant: Acrux DDS Pty Ltd
    Inventors: Timothy Matthias Morgan, Nina Frances Wilkins, Kathryn Traci-Jane Klose, Barrie Charles Finnin, Barry Leonard Reed
  • Patent number: 8993520
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: March 31, 2015
    Assignee: Acrux DDS Pty Ltd
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Publication number: 20150088080
    Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.
    Type: Application
    Filed: June 27, 2014
    Publication date: March 26, 2015
    Applicant: Acrux DDS Pty Ltd
    Inventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
  • Publication number: 20150087623
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 8, 2014
    Publication date: March 26, 2015
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • Patent number: 8807861
    Abstract: An implement 1 for applying a volume of liquid to a treatment surface can include a support 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of using this system are described.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 19, 2014
    Assignee: Acrux DDS Pty Ltd.
    Inventors: Peter Bayly, Mark Simon Bayly, Magnus Ahlstrom, Adam Charles Watkinson
  • Publication number: 20130316996
    Abstract: A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents; one or more dermal penetration enhancers; and a volatile pharmaceutically acceptable carrier comprising a volatile solvent; and wherein the physiologically active agent and dermal penetration enhancer form an amorphous deposit upon evaporation of the volatile carrier, said amorphous deposit forming a reservoir within the stratum corneum; and (A) wherein the composition has a release rate profile of physiologically active agent so as to provide a ratio of the maximum concentration (Cmax) to the average concentration (Cavg) for the physiologically active agent over the dosage interval within the range of 1 to 10.
    Type: Application
    Filed: December 11, 2012
    Publication date: November 28, 2013
    Applicant: Acrux DDS Pty Ltd
    Inventor: Acrux DDS Pty Ltd
  • Publication number: 20130317122
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: May 6, 2013
    Publication date: November 28, 2013
    Applicant: Acrux DDs Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Publication number: 20130317462
    Abstract: A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: May 6, 2013
    Publication date: November 28, 2013
    Applicant: Acrux DDS Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Publication number: 20130211350
    Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 15, 2013
    Applicant: Acrux DDS Pty Ltd
    Inventor: Acrux DDS Pty Ltd
  • Patent number: D749225
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: February 9, 2016
    Assignee: ACRUX DDS PTY LTD
    Inventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever
  • Patent number: D750788
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: March 1, 2016
    Assignee: ACRUX DDS PTY LTD
    Inventors: Shu Kuen Chang, Alain Regard, Anastasios G. Karahalios, Mark LaFever